AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.028

-0.002-6.67%

Volume:42.69M

Turnover:1.21M

Market Cap:76.17M

PE:-0.61

High:0.030

Open:0.030

Low:0.027

Close:0.030

52wk High:0.475

52wk Low:0.027

Shares:2.72B

Float Shares:1.72B

Volume Ratio:1.31

T/O Rate:2.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.046

EPS(LYR):-0.047

ROE:-121.11%

ROA:-53.38%

PB:1.41

PE(LYR):-0.60

Loading ...

Overview Company News Filings

Botanix Pharmaceuticals Ltd-Botanix Q3 FY26 Investor Update Webinar Presentation

THOMSON REUTERS

BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier

BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions

Botanix Pharmaceuticals - Piramal to Commence Development Services , Serve as Alternate Commercial Supplier of Sofpironium Bromide, API in Sofdra

THOMSON REUTERS

Botanix Pharmaceuticals Defers API Purchases to 2027, 2028 Under Amended Supply Agreement

MT Newswires Live

Botanix Pharmaceuticals' Axillary Hyperhidrosis Product Outsells Competing Product, Says Euroz Hartleys

MT Newswires Live

BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million

Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln

THOMSON REUTERS

Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure

A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings

Simply Wall St.

Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low

MT Newswires Live

BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement

Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share

THOMSON REUTERS

Danantara Names Five Chinese Finalists for Waste-to-Energy Projects

BRIEF-Botanix Pharmaceuticals Requests Trading Halt

Botanix Pharmaceuticals Ltd - Requests Trading Halt for Potential Capital Raising

THOMSON REUTERS

Blue Ocean Technologies Announces Executive Changes

NetAssist Strengthens SOC Capabilities with Graylog Security

Indonesia Joins Nexus Project to Strengthen Cross-Border Payments

Botanix Pharmaceuticals Hosts Quarterly Update Webinar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","market":"AU","secType":"STK","nameCN":"BOTANIX PHARMACEUTICALS LTD","latestPrice":0.028,"timestamp":1777529520000,"preClose":0.03,"halted":0,"volume":42689108,"delay":0,"changeRate":-0.06666666666666661,"nameEN":"BOTANIX PHARMACEUTICALS LTD","floatShares":1717605114,"shares":2720262800,"eps":-0.046233,"marketStatus":"Not Yet Opened","change":-0.002,"latestTime":"04-30 16:12:00 AEST","open":0.03,"high":0.03,"low":0.027,"amount":1213544,"amplitude":0.1,"askPrice":0.028,"askSize":1000000,"bidPrice":0.027,"bidSize":2848387,"shortable":3,"etf":0,"ttmEps":-0.046233,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1777593600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.03,"openAndCloseTimeList":[[1777507200000,1777528800000]],"volumeRatio":1.308687,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BOT.AU","preClose":0.03,"auctionPrice":0.028,"auctionVolume":8001334,"auction":3,"marketStatus":"盘后竞价","timestamp":1777529400589}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","floatShares":1717605114,"roa":"-53.38%","roe":"-121.11%","lyrEps":-0.046827,"volumeRatio":1.308687,"shares":2720262800,"dividePrice":0,"high":0.03,"amplitude":0.1,"preClose":0.03,"low":0.027,"week52Low":0.027,"pbRate":"1.41","psRate":"3.48","week52High":0.475,"institutionHeld":0,"latestPrice":0.028,"committee":0.480302,"eps":-0.046233,"divideRate":0,"volume":42689108,"delay":0,"ttmEps":-0.046233,"open":0.03,"prevYearClose":0.135,"prevWeekClose":0.033,"prevMonthClose":0.042,"prevQuarterClose":0.042,"fiveDayClose":0.032,"twentyDayClose":0.042,"sixtyDayClose":0.105},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631532087","title":"Botanix Pharmaceuticals Ltd-Botanix Q3 FY26 Investor Update Webinar Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631532087?lang=en_us&edition=fundamental","pubTime":"2026-04-29 06:54","pubTimestamp":1777416892,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUE41ZQWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627260648","title":"BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier","url":"https://stock-news.laohu8.com/highlight/detail?id=2627260648","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627260648?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:03","pubTimestamp":1776326609,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API SupplierApril 16  - Botanix Pharmaceuticals Ltd BOT.AX:BOTANIX REACHES TERM SHEET AGREEMENT WITH SECOND API SUPPLIERPIRAMAL TO COMMENCE DEVELOPMENT SERVICES , SERVE AS ALTERNATE COMMERCIAL SUPPLIER OF SOFPIRONIUM BROMIDE, API IN SOFDRAFurther company coverage: BOT.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Y0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BOT.AU","BK7502","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627263405","title":"BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2627263405","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627263405?lang=en_us&edition=fundamental","pubTime":"2026-04-16 12:06","pubTimestamp":1776312376,"startTime":"0","endTime":"0","summary":"BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions** Shares of Australia's Botanix Pharmaceuticals BOT.AX surge as much as 22.2% to A$0.04, their highest level since July 9, 2025** Highest level since April 2** Dermatology co reaches term sheet agreement with PPL Pharma Solutions Riverview for manufacturing and supply arrangement** Under deal, PPL to start certain development services, serve as alternate commercial supplier of Sofpironium Bromide ** About 101.5 million shares change hands, 5.4 times the 30-day avg** Down 71.1% YTD, including the session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nL6N40Z0A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOT.AU","BK7508","BK7502","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627557552","title":"Botanix Pharmaceuticals - Piramal to Commence Development Services , Serve as Alternate Commercial Supplier of Sofpironium Bromide, API in Sofdra","url":"https://stock-news.laohu8.com/highlight/detail?id=2627557552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627557552?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293499,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0YC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BOT.AU","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623536172","title":"Botanix Pharmaceuticals Defers API Purchases to 2027, 2028 Under Amended Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623536172","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623536172?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:15","pubTimestamp":1774833312,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  said it has amended its active pharmaceutical ingredient  supply agreement with Kaken Pharmaceutical, rescheduling purchases to December 2027 and December 2028 from the previously set dates for April 2026 and January 2027, according to a Monday Australian bourse filing.The company said following a recent API purchase earlier this month, no further API purchases are required before December 2027, while activities continue to establish an alternate API supplier for Sofpironium Bromide with a view to de-risking the supply chain and achieving potential savings of 25% to 40% in cost of goods sold.Deferring the purchases, in conjunction with proceeds from the current capital raise if approved, is expected to strengthen Botanix's ability to pursue its plans for Sofdra and its fulfillment platform, the filing added.The company's shares fell 2% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6100","BK6520","BK7103","BK7096","OTX.SI","BK7502","BOT.AU","BK4023","BK4551","BK4503","API.AU","API","BK4535","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618398345","title":"Botanix Pharmaceuticals' Axillary Hyperhidrosis Product Outsells Competing Product, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2618398345","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618398345?lang=en_us&edition=fundamental","pubTime":"2026-03-10 13:11","pubTimestamp":1773119492,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals'  axillary hyperhidrosis product, Sofdra, has exceeded the competing product Qbrexza in the week ending February 27, according to a Tuesday note by Euroz Hartleys.Euroz Hartleys said that an estimated 2,726 prescriptions of Sofdra were dispensed in the period, according to Symphony Health, which shows 15% week-on-week growth and the highest weekly prescription level on record.Given its role as corporate adviser, the research firm said it is restricted from providing a price target or rating at this time.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BOT.AU","BK7096","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614072882","title":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614072882","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614072882?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:57","pubTimestamp":1772179062,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 MillionFeb 27 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:HY LOSS ATTRIBUTABLE A$33.2 MILLIONREVENUE FROM ORDINARY ACTIVITIES FOR HY A$16.5 MILLIONFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614000023","title":"Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614000023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614000023?lang=en_us&edition=fundamental","pubTime":"2026-02-27 12:21","pubTimestamp":1772166100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BOT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614388890","title":"Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614388890","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614388890?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:28","pubTimestamp":1772008080,"startTime":"0","endTime":"0","summary":"TradingKey - The Bank of Thailand (BOT) has lowered its policy rate to 1.00%, the lowest level since September 2022. This marks the institution's second consecutive easing measure aimed at supporting economic recovery and addressing the pain points of sluggish domestic growth and elevated deflationa","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/economic-indicator/261618327-thailand-bot-interest-rates-thb-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BOT.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612413214","title":"A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413214","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 12:44","pubTimestamp":1771389874,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure.\nSee our latest analysis for Botanix Pharmaceuticals.\nThat equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4215","BK4588","DCF","BK4585","BK7096","BOT.AU","EQR","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612436270","title":"Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2612436270","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612436270?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:37","pubTimestamp":1771295855,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  received firm commitments to raise about  AU$40 million via a two-tranche placement of 666.7 million shares at AU$0.06 per share, according to a Tuesday filing with the Australian bourse.The offer price represents an 45.5% discount to the stock's last traded price before the trading halt on Feb.13, the filing said.Tranche one is expected to raise around AU$14.9 million by issuing 247.9 million shares at the offer price, while tranche two aims to raise about AU$25.1 million through the issue of 418.7 million shares, subject to shareholder approval, the filing added.The company will also allow eligible shareholders to participate in a share purchase plan to raise up to AU$5 million at the same price, the company said.Funds raised will be used towards the purchase of active pharmaceutical ingredient  and costs to obtain a second API supplier, the company added.The new shares are expected to settle in early April.Shares of the company fell 39% in recent Tuesday tra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7502","BK4535","BK4503","BOT.AU","BK4023","BK7096","API.AU","BK4551","BK7508","API","BK7103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612403435","title":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612403435","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612403435?lang=en_us&edition=fundamental","pubTime":"2026-02-17 09:23","pubTimestamp":1771291417,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement Feb 17 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:FIRM COMMITMENTS FOR A$40 MILLION TWO-TRANCHE PLACEMENT AT A$0.06 PER NEW SHAREFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7096","BOT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612438681","title":"Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612438681","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612438681?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:43","pubTimestamp":1771281803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7502","BOT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611152164","title":"Danantara Names Five Chinese Finalists for Waste-to-Energy Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2611152164","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611152164?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:24","pubTimestamp":1770971068,"startTime":"0","endTime":"0","summary":"TEMPO.CO,Jakarta-A number of companies from China have dominated the selection of winners for the Waste-to-Energy Electricity Generation  project tender managed by Danantara Indonesia. Out of 24 international companies that passed the final selection, five are Chinese corporations now competing to secure initial phase projects across four cities.Lead of Waste-to-Energy at Danantara Indonesia, Fadli Rahman, stated that all participants are required to form a consortium with local partners. \"We hope that the consortium can provide technology transfer to local companies or local governments,\" said Fadli, quoted from a written statement on Friday, February 13, 2026.","market":"us","thumbnail":"https://statik.tempo.co/data/2022/06/28/id_1121255/1121255_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2022/06/28/id_1121255/1121255_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2086994/danantara-names-five-chinese-finalists-for-waste-to-energy-projects","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2086994/danantara-names-five-chinese-finalists-for-waste-to-energy-projects","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7502","601827","BK7508","BK7096","BK0218","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611900983","title":"BRIEF-Botanix Pharmaceuticals Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2611900983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611900983?lang=en_us&edition=fundamental","pubTime":"2026-02-13 09:49","pubTimestamp":1770947363,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Requests Trading HaltFeb 13 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:REQUESTS TRADING HALT FOR POTENTIAL CAPITAL RAISINGFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611169904","title":"Botanix Pharmaceuticals Ltd - Requests Trading Halt for Potential Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611169904?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:31","pubTimestamp":1770942672,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610655881","title":"Blue Ocean Technologies Announces Executive Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2610655881","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610655881?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643800,"startTime":"0","endTime":"0","summary":"Appoints Robert Virgilio as Chief Compliance Officer of Blue Ocean ATS & Expands South Korean Team with Addition of Daehyun Kim in new Trade Support Role. Virgilio holds a Bachelor of Science from Niagara University, an MBA from St. John's University, and FINRA Series 4, 7, 9/10, 14, 24, and 57 licenses. He is a past member of the SIFMA Self-Regulation and Supervisory Practices Committee, and NYSE Market Compliance Advisory Committee. Kim holds a Master of Commerce  from the University of Sydney and a Bachelor's/Diploma in Information Technology from Queensland University of Technology. He is a Certified Securities and Derivatives Investment Advisor (Korea Financial Inv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-announces-executive-changes-302681886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NMS","BK7096","BK7502","BK4161","ATS","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610755505","title":"NetAssist Strengthens SOC Capabilities with Graylog Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2610755505","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610755505?lang=en_us&edition=fundamental","pubTime":"2026-02-09 08:00","pubTimestamp":1770595200,"startTime":"0","endTime":"0","summary":"Delivers Faster Detection and Scalable Operations for Enterprise Customers in Regulated Industries. PETALING JAYA, Malaysia and HOUSTON, Feb. 8, 2026 /PRNewswire/ --NetAssist  Sdn Bhd, a leading Managed Security Services Provider , today announced it has enhanced its security operations using Graylog Security, a modern SIEM platform built to remove the barriers that slow security teams. The deployment enables NetAssist to improve threat detection speed, scale log data processing, and increase operational efficiency for its customers in critical infrastructure, banking, and national payment networks.\"As customer security environments grow more complex, we prioritize technologies that allow us to provide holistic cyber resilience, and through our SOCs, to respond rapidly, scale securely, and deliver outcomes with consistency,\" said Hon Fun Ping, Managing Director of NetAssist. \"Graylog gives us the performance and flexibility to do just that, without compromising on visibility or cost.\".","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/netassist-strengthens-soc-capabilities-with-graylog-security-302681754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7061","SOC","BK4213","SOC.AU","BK4588","BK4585","BK4103","BK7096","BOT.AU","BK4220","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608841942","title":"Indonesia Joins Nexus Project to Strengthen Cross-Border Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2608841942","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608841942?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:36","pubTimestamp":1770089771,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-Bank Indonesia  has joined the Nexus project initiated by the Bank for International Settlements , signifying the central bank's commitment to enhance the connectivity of cross-border payment systems.Bank Indonesia will play a role in preparing and implementing the Nexus along with five central banking partners: Bank Negara Malaysia , Bangko Sentral ng Pilipinas , Monetary Authority of Singapore , Bank of Thailand , and Reserve Bank of India .BI Governor Perry Warjiyosaid Indonesia's participation in Nexus serves as a strategic move to provide efficient and affordable cross-border payment solutions for Indonesian people and businesses.","market":"us","thumbnail":"https://statik.tempo.co/data/2025/11/29/id_1444271/1444271_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/11/29/id_1444271/1444271_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2084658/indonesia-joins-nexus-project-to-strengthen-cross-border-payments","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2084658/indonesia-joins-nexus-project-to-strengthen-cross-border-payments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4585","BK7096","SG9999001440.SGD","LU0170899867.USD","BIS","BOT.AU","BIS.AU","LU2413666004.HKD","BK7508","LU1543694498.USD","BK4588","LU1620156130.USD","LU2413665964.HKD","LU1620156213.USD","BK7502","BK4086","IPS","MAS","BK7129","LU1165135440.EUR","LU1721427968.SGD","LU1596574779.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605594394","title":"Botanix Pharmaceuticals Hosts Quarterly Update Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2605594394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605594394?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:12","pubTimestamp":1769055174,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd. will host a Quarterly Update Webinar on Tuesday, 27 January. The event will feature the executive team presenting the Company's Quarterly Activity Report and 4C Quarterly Cash Flow Report. Pre-registration is required for participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Botanix Pharmaceuticals Ltd. published the original content used to generate this news brief on January 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL4rPjrH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7508","BK7096","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}